Acloproxalap

DB21553InvestigationalSmall molecule

Acloproxalap is a small molecule drug. Acloproxalap is under investigation in clinical trial NCT06685692 (A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)).... Acloproxalap has a monoisotopic molecular weight of 202.11 Da.

Formula / weight: C₁₂H₁₄N₂O · 202.257 g/mol (avg)
Code names: ADX-629

Resolves to

Compound

UNII9JE45QU76CCAS1824609-67-7ChEMBLCHEMBL4994054

Structure

InChIKeyNOFRQDXKZDAYGB-UHFFFAOYSA-NSMILESCC(C)(O)C1=C(N)C=C2C=CC=CC2=N1

What you can answer from here — as of September 12, 2026

9Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of Acloproxalap, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account